RootsAnalysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”
Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely adoption of these therapeutics over the nextdecade. It features an in-depth analysis, highlighting the capabilities ofvarious stakeholders engaged in this domain. In addition to other elements, thestudy includes:
· A detailed assessment of the current marketlandscape of ADCs.
· Elaborate profiles of the clinical stagecompanies (shortlisted based on phase of development of the lead drug) andtheir respective product portfolios.
· An analysis of the most commonly targetedtherapeutic indications and details of ADC candidates being developed againstthem, highlighting key epidemiological facts about the diseases and currentlyavailable treatment options, other than ADCs.
· A list of key opinion leaders (KOLs) withinthis domain.
· An insightful competitiveness analysis ofbiological targets.
· An analysis of the partnerships that havebeen established in the recent past.
· An analysis of the investments made.
· A study of the various grants that have beenawarded to research institutes engaged in projects related to ADCs, between2011 and 2019 (till April).
· An elaborate discussion on the variousstrategies that can be adopted by the drug developers across keycommercialization stages, namely prior to product launch, during / post launch.
· An analysis of the key promotional strategiesthat have been adopted by the developers of marketed products.
· An assessment of the various therapeuticsthat are being evaluated in combination with ADCs.
· A review of the evolution of ADC conjugationtechnologies.
· An overview of the studies conducted tobetter analyze non-clinical data and support first-in-human (FIH) doseselection in ADCs.
· An elaborate discussion on various factorsthat form the basis for the pricing of ADC products.
· A case study on manufacturing of ADCs,highlighting the key challenges, and a list of contract service providers thatare involved in this domain.
· A case study on companies offering companiondiagnostics.
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Typeof payload
· MMAE
· DM4
· Camptothecin
· AM1
· MMAF
Typeof linker
· VC
· Sulfo-SPDB
· SMCC
· VA
· Hydrazone linker
· Others
TargetIndications
· Breast Cancer
· Lymphoma
· Leukemia
· Urothelial cancer
· Lung cancer
· Ovaria cancer
· Others
TargetAntigen
· CD30
· HER2
· CD22
· CD33
· Others
· Small Molecule
TechnologyProviders
· Seattle Genetics
· ImmunoGen
· StemCentRx
· Immunomedics
· Others
KeyGeographies
· North America
· Europe
· Asia Pacific
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies:
· Alan Burnett (Professor, School of Medicine,Cardiff University)
· Aldo Braca (President and Chief ExecutiveOfficer) and Giorgio Salciarini (Technical Business Development Senior Manager,BSP Pharmaceuticals)
· Anthony DeBoer (Director, BusinessDevelopment, Synaffix)
· Christian Bailly (Director of CDMO, PierreFabre)
· Christian Rohlff, (Chief Executive Officerand Founder, Oxford BioTherapeutics)
· Denis Angioletti (Chief Commercial Officer,Cerbios-Pharma)
· John Burt (Chief Executive Officer, Abzena)
· Jennifer L. Mitcham (Director, SMARTag ADCsand Bioconjugates) and Stacy McDonald (Group Product Manager, Catalent PharmaSolutions)
· Laurent Ducry (Head of BioconjugatesCommercial Development, Lonza)
· Mark Wright (Site Head, Piramal Healthcare)
· Sasha Koniev (Chief Executive Officer &Co-Founder, Syndivia)
· Tatsuya Okuzumi (Associate General Manager,Ajinomoto Bio-Pharma Services)
· Toshimitsu Uenaka (Executive Director) andTakashi Owa (Chief Innovation Officer, Eisai)
· Wouter Verhoeven (Chief Business Officer, NBE-Therapeutics)
Keycompanies covered in the report
· Bristol Myers Squibb
· AbbVie
· Astellas Pharma
· AstraZeneca
· Daiichi Sankyo
· Pfizer
· Roche / Genentech
· Synthon
· Bayer HealthCare
· Biotest Pharmaceuticals
Requestfor PDF Sample of this Report:
https://www.rootsanalysis.com/reports/270/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
AlsoVisit Our Latest Publication
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
